The efficacy of letrozole to prevent ovarian hyperstimulation symdrome

JRCT ID: jRCTs041190131

Registered date:26/03/2020

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: Ovarian hyperstimulation syndorome
• Date of first enrollment: 26/03/2020
• Target sample size: 80
• Study type: Interventional
• Intervention(s): Drug administration

Outcome(s)

• Primary Outcome: Improvement of ovarian hyperstimulation syndrome after intervention
• Secondary Outcome: Serum LH levels, Serum E2 levels, findings of ultrasonography

Key inclusion & exclusion criteria

• Age minimum: >= 18age old
• Age maximum: <= 50age old
• Gender: Female
• Include criteria: A female between the ages of 18 and 50 who does controlled ovatian stimulation with assisted reproductive medicine. When the estradiol level is 3000 pg / ml or more on the decided day of oocyte pick up.
• Exclude criteria: When oocyte pick up was stopped. No consent was obtained. Others deemed inappropriate by the attending physician.

Related Information

• Primary Sponsor: Osuka Satoko